Clinical Trials Browser

Phase 1 × Primary Central Nervous System Lymphoma (PCNSL) × 90 days × Clear all

NCT07082868 2026-02-17

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

Phase 1 Recruiting

Primary Central Nervous System Lymphoma (PCNSL)